Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 28 Oct 2021 |
2 | Reply to Exam Report (MIS-R) | 07 Jan 2022 |
3 | Authorization Letter | 10 Jan 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 13 Jan 2023 |
5 | Journal Copy | 16 Nov 2023 |
6 | TM-O(NOTICE OF OPPOSITION) | 13 Dec 2023 |
7 | Annexure -1 under rule 46 | 10 Jun 2024 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 10 Jun 2024 |
8 | Annexure -1 under rule 46 | 10 Jun 2024 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 10 Jun 2024 |
1 | EXAMINATION REPORT | 12640878 | 14 Dec 2021 | |
2 | Hearing Notice (Show Cause) | 14451363 | 08 Dec 2022 | |
3 | Tribunal Accepted Notice for : 5191192 | 15750495 | 6093460 | 02 Aug 2023 |
4 | Opposition Notice | 16821937 | 6391174 | 14 Dec 2023 |
5 | Opposition Counter Statement | 17383549 | 6544637 | 12 Feb 2024 |
As per IP India data the trademark was applied on 28 October 2021.
STRIDES PHARMA SCIENCE applied for Striglimy m1 sr.
Listed class of trademark Striglimy m1 sr is 5.
Striglimy m1 sr is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 5191192
Trademark application was filed by the following attorney agent:
Altacit Global
The trademark is categorized as WORD.